Results 211 to 220 of about 26,327 (353)

The tale of donanemab: God is in the details. [PDF]

J Alzheimers Dis
Saido TC, Iwata N.
europepmc   +1 more source

Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials [PDF]

, 2015
Chirag Bavishi, Franz H. Messerli, Bernard Kadosh, Luís M. Ruilope, Kazuomi Kario   +4 more
openalex   +1 more source

Real‐life implementation of guideline‐recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE‐HF

European Journal of Heart Failure, EarlyView.
Primary results of TITRATE‐HF. GRMT, guideline‐recommended medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; LVEF, left ventricular ejection fraction. Abstract Aims Guideline‐recommended medical therapy (GRMT) improves outcomes in heart failure (HF) with reduced ejection fraction (HFrEF), yet implementation ...
Jishnu Malgie, Mariëlle I. Wilde, Stefan Koudstaal, Robert Denham, Carlos A. da Fonseca, Henk P. Swart, Clara E.E. van Ofwegen, Ayten Yilmaz, Ron Pisters, Gerard C.M. Linssen, Nikola Faber, Loek van Heerebeek, Julio E.C. van de Swaluw, Rudolf A. de Boer, Hans‐Peter Brunner‐La Rocca, Jasper J. Brugts   +15 more
wiley   +1 more source

Impact of Sitagliptin on Neprilysin and Glycemic Control in Newly Diagnosed Type 2 Diabetes Patients. [PDF]

Med Sci Monit
Gül CB, Oruc A, Cander S, Aydemir E, Oz Gül O.   +4 more
europepmc   +1 more source

APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression [PDF]

, 2015
Marcus O.W. Grimm, Janine Mett, Christoph P. Stahlmann, Sven Grösgen, Viola J. Haupenthal, Tamara Blà ⁄ mel, Benjamin Hundsdörfer, Valerie C. Zimmer, Nadine Mylonas, Heikki Tanila, Ulrike Mà ⁄ ller, Heike S. Grimm, Tobias Hartmann   +12 more
openalex   +1 more source

Ferric derisomaltose augments intrinsic skeletal muscle electron transport chain activity in heart failure: A FERRIC‐HF II molecular substudy

European Journal of Heart Failure, EarlyView.
FERRIC‐HF II molecular substudy. FDI, ferric derisomaltose. Aims Skeletal muscle energetic augmentation might be a mechanism via which intravenous iron improves symptoms in heart failure, but no direct measurement of intrinsic mitochondrial function has been performed to support this notion.
Mohamad F. Barakat, Nelson Amaral, Daniel Brayson, George Amin‐Youssef, Huda Abu‐Own, Salma Ayis, Francesco Papalia, Fadi Jouhra, Adam Nabeebaccus, Mark Monaghan, Gerry Carr‐White, Alison Sleigh, Geoffrey Charles‐Edwards, Ajay M. Shah, Graham J. Kemp, Andrew J. Murray, Darlington O. Okonko   +16 more
wiley   +1 more source

The effect of sacubitril/valsartan on urinary C-peptide excretion and endogenous insulin secretory capacity in a patient with type 2 diabetes: a case report. [PDF]

J Pharm Health Care Sci
Onodera S, Miyamae M, Higuchi I, Nashimoto S, Nakamura A, Sugawara M, Takekuma Y.   +6 more
europepmc   +1 more source

Neprilysin Impedes Islet Amyloid Formation by Inhibition of Fibril Formation Rather Than Peptide Degradation

, 2010
Sakeneh Zraika, Kathryn Aston‐Mourney, Peter Marek, Rebecca L. Hull, Pattie S. Green, Jayalakshmi Udayasankar, Shoba Subramanian, Daniel P. Raleigh, Steven E. Kahn   +8 more
openalex   +1 more source

Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies [PDF]

, 2016
Michaela Auer‐Grumbach, Stefan Toegel, Maria Schabhüttl, Daniela Weinmann, Catharina Chiari, David Bennett, Christian Beetz, Dennis Klein, Peter M. Andersen, Ilka Böhme, Regina Fink‐Puches, Michael Gonzalez, Matthew Harms, William W. Motley, Mary M. Reilly, Wilfried Renner, Sabine Rudnik‐Schöneborn, Beate Schlotter‐Weigel, Andreas C. Themistocleous, Jochen H. Weishaupt, Albert C. Ludolph, Thomas Wieland, Feifei Tao, Lisa Abreu, Reinhard Windhager, Manuela Zitzelsberger, Tim M. Strom, Thomas Walther, Steven S. Scherer, Stephan Züchner, Rudolf Martini, Jan Senderek   +31 more
openalex   +1 more source

Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study

European Journal of Heart Failure, EarlyView.
Stephen J. Greene, Stefano Corda, Ciaran J. McMullan, Giovanni Palombo, Christina Schooss, Vanja Vlajnic, Katrin Walkamp, Michele Senni, on behalf of the VELOCITY investigators   +8 more
wiley   +1 more source